UTPA is hosting three conferences this week that discuss health care issues

Breaking News
907

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

On Wednesday, March 26, UTPA’s Bioethics Research Conference will host several panels that discuss the ethical implications to many medical and health issues, including: “Keeping People Alive Against Their Will in Texas: Examining Cases Like Marlise Muñoz” and “Are Celebrities Killing Us? The Vaccination Scare and the Impact of Celebrities on Public Health.”

On Thursday, March 27, The College of Social and Behavioral Sciences will host its Eighth Annual Research Conference . This year’s focus is Health and Health Policy in the Social Sciences.

On Friday, March 28, The College of Health Sciences and Human Services will host its Second Annual MORE Health @UTPA, which will have presentations on medical research. MORE Health will conclude with a community health fair Saturday, March 29 at the UTPA Ballroom where participants can receive free health screenings and other services.

- Advertisement -

Below, please find a link to the agendas for the conferences.  Thank you all for your continued support of UTPA.

https://www.utpa.edu/features/more-health/

 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Are Spices the Solution to Eradicate Cancer?
Next article
Congressman Cuellar said, “Don’t Wait until the Last Minute to Enroll in Health Insurance”

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -